Monday, December 1, 2008 - 11:44PM EST

Drug Therapy

11. Ropinirole: new indication. Restless legs: disproportionate adverse effects.

Author
Institution
Journal
Prescrire Int. 2006 Oct;15(85):173-6.
Abstract URL
Click here to view abstract

12. Ropinirole (Requip) for restless legs syndrome.

Author
Institution
Journal
Med Lett Drugs Ther 2005 Aug 1;47(1214):62-4.

13. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.

Author
Konofal, Eric; Arnulf, Isabelle; Lecendreux, Michel; Mouren, Marie-Christine;
Institution
Service de Psychopathologie de l'Enfant et de l'Adolescent, Hopital Robert Debre, Paris, France.
Journal
Pediatr Neurol 2005 May;32(5):350-1.
Abstract URL
Click here to view abstract

14. Role of medications in the etiology and treatment of restless leg syndrome.

Author
Neafsey, Patricia J;
Institution
Journal
Home Healthc Nurse 2005 Apr;23(4):207-9.

15. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.

Author
von Spiczak, Sarah; Whone, Alan L; Hammers, Alexander; Asselin, Marie-Claude; Turkheimer, Federico; Tings, Tobias; Happe, Svenja; Paulus, Walter; Trenkwalder, Claudia; Brooks, David J;
Institution
Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, UK. sarah.v.s@gmx.de
Journal
Brain 2005 Apr;128(Pt 4):906-17. Epub 2005 Feb 23.
Abstract URL
Click here to view abstract
Pages: 1 2